Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.54 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylformamide SCHEMBL27570110 | 0.90 | ERN1 (0.54) | ERN1HSD17B10AMY1AVCAM1KMT2A | |
| SCHEMBL1195413 | 0.86 | HSD17B10 (0.62) | ERN1HSD17B10AMY1AVCAM1KMT2A | |
| Glycine SCHEMBL8213987 | 0.86 | ERN1 (0.54) | ERN1HSD17B10AMY1AKMT2AMAPT | |
| SCHEMBL6536285 | 0.84 | ALDH1A1 (0.58) | ERN1HSD17B10AMY1AVCAM1KMT2A | |
| SCHEMBL2652355 | 0.83 | ERN1 (0.69) | ERN1HSD17B10KMT2AMAPTHTT | |
| Cyclohexylamine SCHEMBL7792901 | 0.83 | ERN1 (0.48) | ERN1HSD17B10AMY1AKMT2AMAPT | |
| SCHEMBL8700059 | 0.83 | ERN1 (0.55) | ERN1HSD17B10AMY1AVCAM1KMT2A | |
| SCHEMBL13689920 | 0.82 | HSD17B10 (0.62) | ERN1HSD17B10AMY1AVCAM1KMT2A | |
| SCHEMBL16951936 | 0.82 | HSD17B10 (0.62) | ERN1HSD17B10AMY1AVCAM1KMT2A | |
| SCHEMBL9551019 | 0.82 | HSD17B10 (0.56) | ERN1HSD17B10AMY1AVCAM1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 972 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121379351-B | Nano ceramic ultra-high hardness powder coating and preparation method thereof | 广东桑瑞斯环保新材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2024-02-29 | — | — | US | claimed |
| CN-113214182-B | Benzisothiazole compound and preparation method thereof | 佛山湘潭大学绿色智造研究院 | 2022-12-23 | — | — | CN | claimed |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2021-09-23 | — | — | US | claimed |
| CN-113214182-A | Benzisothiazole compound and preparation method thereof | 佛山湘潭大学绿色智造研究院 | 2021-08-06 | — | — | CN | claimed |
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2020-08-06 | — | — | US | claimed |
| CN-103539789-A | Preparation method of quinazoline derivative as tyrosine kinase inhibitor | SOUTHEAST PHARMACEUTICALS CO LTD | 2014-01-29 | — | — | CN | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| US-20030175848-A1 | Substituted dithiobisnitrobenzenes and their applications | INSTITUT PASTEUR DE LILLE | 2003-09-18 | — | — | US | claimed |
| EP-1082297-B1 | SUBSTITUTED DITHIO-BIS-NITROBENZENES AND THEIR APPLICATIONS | PASTEUR INSTITUT (FR) | 2003-06-18 | — | — | EP | claimed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998002741-A9 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | — | 1998-05-22 | — | — | WO | claimed |
| WO-1998002741-A1 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-01-22 | — | — | WO | claimed |
| EP-0461531-B1 | Process for the purification of 2-chloro-5-nitrobenzaldehyde or their acetals | BASF AG (DE) | 1994-09-14 | — | — | EP | claimed |
| US-5149882-A | PURIFICATION OF 2-CHLORO-5-NITROBENZALDEHYDE OR ACETALS THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-22 | — | — | US | claimed |
| EP-0461531-A2 | Process for the purification of 2-chloro-5-nitrobenzaldehyde or their acetals | BASF Aktiengesellschaft (DE) | 1991-12-18 | — | — | EP | claimed |
| US-4456772-A | Process for the preparation of optionally substituted fluoro-nitro-benzaldehydes | BAYER AKTIENGESELLSCHAFT (DE) | 1984-06-26 | — | — | US | claimed |
| US-4380629-A | Styryl-like compounds showing a color-developing and bleaching behavior with improved stability and prolonged lifetime | MATSUSHITA ELECTRIC INDUSTRIAL COMPANY, LIMITED (JP) | 1983-04-19 | — | — | US | claimed |
| US-4147862-A | Method of preparing styryl-like compounds | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1979-04-03 | — | — | US | claimed |
| US-3951993-A | HYPOTENSIVE, CORONARY VESSEL DILATORS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | ERN1 4509/4885HSD17B10 4210/4885AMY1A 4170/4885 |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | ERN1 4304/4885HSD17B10 4375/4885AMY1A 4136/4885 |
| US-20030175848-A1 | Substituted dithiobisnitrobenzenes and their applications | TST, TXN, NQO1 | ERN1 3150/4885HSD17B10 459/4885AMY1A 4040/4885 |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | ERN1 4304/4885HSD17B10 4375/4885AMY1A 4136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.